Expert Insights on Neurological Research

Shutterstock 89653558 Scaled

Differentiating Between Concussion, Psychological Symptoms, and Malingering Using the ImPACT Test

The Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) is a vital tool in the assessment of concussions, providing objective data on cognitive function and symptomatology. This article explores how ImPACT can differentiate between symptoms originating from concussions, psychological conditions, and malingering. Through cognitive assessments, symptom tracking, baseline comparisons, and validity indicators, ImPACT aids clinicians in distinguishing between these conditions. However, it emphasizes that ImPACT should be part of a comprehensive clinical evaluation for accurate diagnosis and effective management.

Differentiating Between Concussion, Psychological Symptoms, and Malingering Using the ImPACT Test Read Post »

X6pfyknb

Blood biomarkers in mTBI

Several studies have demonstrated that elevated levels of S100B, GFAP, UCH-L1, and NFL correlate with the presence and severity of mTBI. S100B, a marker of astrocytic damage, has been shown to have high sensitivity but moderate specificity for mTBI. GFAP, another astrocytic marker, exhibits higher specificity and is particularly useful in differentiating mTBI from other conditions. UCH-L1, a marker of neuronal cell body injury, and NFL, indicative of axonal damage, both show promise in reflecting the extent of neuronal injury and predicting recovery outcomes. Additionally, combinations of these biomarkers may enhance diagnostic accuracy and provide more comprehensive insights into the injury mechanisms and prognosis.
The use of blood biomarkers in mTBI offers several advantages, including non-invasiveness, rapid turnaround time, and the potential for point-of-care testing. However, challenges such as variability in biomarker levels due to individual differences, the influence of extracranial injuries, and the need for standardized protocols must be addressed. Further research is required to validate these biomarkers in larger, diverse populations and to establish clear clinical guidelines for their use.

Blood biomarkers in mTBI Read Post »

Shutterstock 1063712879 Scaled

Foreign Accent Syndrome

Foreign Accent Syndrome (FAS) is an uncommon speech disorder where individuals develop a new, seemingly foreign accent in their native language. This review explores FAS within the contexts of functional neurological disorders (FND) and mild traumatic brain injuries (mTBIs).

In FNDs, FAS is often classified as a functional speech disorder, where no definitive structural brain lesions or neurological causes are identified. Cases suggest a psychogenic or functional origin, possibly triggered by psychological stress. Studies highlight that FAS in FNDs features inconsistencies and intermittency in speech patterns, which can occur even in the presence of structural brain damage.

In mTBIs, FAS can emerge without significant structural lesions visible on imaging. Reports indicate that even minor head injuries might lead to FAS, with functional or metabolic brain changes undetected by standard imaging techniques. For instance, abnormal functions in specific brain regions, such as the left dorsolateral inferior frontal gyrus and caudate nucleus, have been implicated.

Overall, the occurrence of FAS in both FNDs and post-mTBI contexts underscores the complexity of this speech disorder and the need for integrated diagnostic and therapeutic approaches. The studies reviewed suggest that functional and metabolic assessments, alongside behavioural interventions, are crucial for understanding and managing FAS effectively.

Foreign Accent Syndrome Read Post »

DALL·E 2024 05 15 15.58.51 An Artistic Conceptual Illustration For A Medical Publication Cover About Functional Neurological Disorders FND. The Image Should Feature A Human Br

Misdiagnosis in Functional Neurological Disorders (FND)

Functional Neurological Disorders (FND) present with symptoms that lack clear organic causes and mimic other neurological disorders. This overlap complicates diagnosis and significantly increases the likelihood of misdiagnosis. Traditionally considered a diagnosis of exclusion, the approach to FND has shifted towards inclusion based on specific clinical indicators. Despite advancements in diagnostic techniques and a growing understanding of FND’s pathophysiology, misdiagnoses remain common. These are often exacerbated by persistent misconceptions, such as viewing FND as solely psychological or suspecting symptom feigning. Misdiagnoses lead to inappropriate treatments, which are costly, potentially harmful, and psychologically damaging to patients. This paper reviews the challenges and impacts of FND misdiagnosis, emphasizes the importance of an informed, multidisciplinary approach for accurate diagnosis, and suggests advancements in neuroimaging and clinical education as critical tools for improvement.

Misdiagnosis in Functional Neurological Disorders (FND) Read Post »

Shutterstock 620683553 Scaled

Diagnosis of functional neurological disorder

he diagnosis of Functional Neurological Disorder (FND) represents a challenging but critical endeavor in neurology and psychiatry, requiring an integrated approach that transcends traditional diagnostic categories. This paper outlines a comprehensive framework for diagnosing FND, emphasizing the importance of direct clinical assessment, the strategic exclusion of other neurological and medical conditions, and the identification of characteristic positive signs. Contrary to being a diagnosis of exclusion, FND involves specific, identifiable signs such as Hoover’s sign, distractibility, and other non-physiological findings. These markers facilitate a positive diagnostic outcome, reinforcing that FND symptoms are genuine and rooted in functional impairments rather than structural abnormalities. Furthermore, the method of communicating the diagnosis to patients significantly affects their understanding, acceptance, and engagement in subsequent treatment, which can include physical therapy, psychotherapy, and medication. By providing a clear diagnostic pathway that incorporates both neurologic and psychiatric expertise, this paper aims to enhance the accuracy of FND diagnoses and improve patient outcomes through tailored, multidisciplinary care.

Diagnosis of functional neurological disorder Read Post »

Shutterstock 1423084877 Scaled

Functional Cognitive Impairment Following Mild Traumatic Brain Injury (mTBI)

Functional cognitive impairment (FCI) post-mild traumatic brain injury (mTBI) presents a significant challenge, often manifesting subtle symptoms that persist well beyond the healing of physical injuries. The primary causative factor is the brain trauma itself, which disrupts normal cognitive functioning and is exacerbated by metacognitive impairments, psychological factors such as depression and anxiety, and physical symptoms like fatigue and headache. Despite normal results on traditional neuropsychological tests, affected individuals may struggle with daily cognitive tasks, impacting their quality of life. While treatment options like transcranial Direct Current Stimulation (tDCS) and cognitive rehabilitation programs show promise, the prognosis for FCI varies widely, dependent on several factors including the severity of the initial injury and individual health conditions. Emerging research using techniques like [18F]fluorodeoxyglucose positron emission tomography ([18F]FDG-PET) offers new insights into prognosis, enhancing understanding and management of FCI.

Functional Cognitive Impairment Following Mild Traumatic Brain Injury (mTBI) Read Post »

Shutterstock 2284571133

Legal and Ethical Concerns in the Diagnosis of Functional Neurological Disorders

Functional Neurological Disorders (FND) are characterized by neurological symptoms that are not explained by identifiable neurological disease. The diagnosis of FND is complex and requires a careful approach to avoid misdiagnosis, which can have significant legal and ethical implications. Misdiagnosis can lead to unnecessary treatments, psychological harm, and a lack of informed consent. Studies have shown that misdiagnosis rates for FND are similar to those for ‘organic’ neurological diseases, and the misdiagnosis of neurological diseases as FND occurs at a similar frequency. The challenge is compounded when patients have comorbid conditions, such as multiple sclerosis, where both conditions need to be treated. Ethical concerns include the potential for stigmatization of patients, the responsibility of healthcare professionals to correct public misinformation, and the importance of accurate communication of diagnoses. Legal concerns revolve around the accuracy of diagnosis, informed consent, and confidentiality. To address these concerns, enhanced training for healthcare providers, development of guidelines for media engagement, and multidisciplinary approaches to assessment and treatment are recommended. The goal is to ensure that patients receive accurate diagnoses and appropriate care, while healthcare providers navigate the ethical and legal landscape with due diligence.

Legal and Ethical Concerns in the Diagnosis of Functional Neurological Disorders Read Post »

Scroll to Top